USD 1.2
(-1.64%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.28 Million USD | 21.72% |
2022 | 1.05 Million USD | 100.0% |
2021 | -484.88 Billion USD | -79359371208.18% |
2020 | 611.00 USD | 0.0% |
2019 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2023 Q2 | 1.53 Million USD | 20.09% |
2023 FY | 1.28 Million USD | 21.72% |
2023 Q3 | 1.28 Million USD | -16.28% |
2023 Q1 | 1.28 Million USD | 21.08% |
2023 Q4 | 1.28 Million USD | 0.0% |
2022 Q3 | 1.05 Million USD | 18.03% |
2022 Q2 | 895.77 Thousand USD | 0.0% |
2022 Q1 | 895.77 Thousand USD | 0.0% |
2022 FY | 1.05 Million USD | 100.0% |
2022 Q4 | 1.05 Million USD | 0.0% |
2021 FY | -484.88 Billion USD | -79359371208.18% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | - USD | -100.0% |
2021 Q3 | 12.59 Thousand USD | 0.0% |
2020 Q4 | 611.00 USD | 0.0% |
2020 FY | 611.00 USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | 73.128% |
Safety Shot Inc | 1.86 Million USD | 31.169% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 99.154% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 98.843% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 80.988% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 96.02% |
Dynavax Technologies Corporation | 53.29 Million USD | 97.585% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 98.039% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 88.951% |
Pacira BioSciences, Inc. | 104.35 Million USD | 98.767% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 77.56% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 77.56% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -58.923% |
Journey Medical Corporation | 10.2 Million USD | 87.391% |
Alpha Teknova, Inc. | 11.59 Million USD | 88.9% |
Procaps Group, S.A. | 96.83 Million USD | 98.671% |
Theratechnologies Inc. | 6.06 Million USD | 78.785% |
Harrow Health, Inc. | 10.86 Million USD | 88.158% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 52.67% |
Biofrontera Inc. | 10.9 Million USD | 88.202% |
DURECT Corporation | 2.21 Million USD | 42.006% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 98.338% |
Cronos Group Inc. | 30.33 Million USD | 95.758% |
OptiNose, Inc. | 8.05 Million USD | 84.018% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -128689300.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | 77.419% |
Organogenesis Holdings Inc. | 28.25 Million USD | 95.445% |
Guardion Health Sciences, Inc. | 2.67 Million USD | 51.93% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 72.081% |
Radius Health, Inc. | 278.64 Million USD | 99.538% |
Universe Pharmaceuticals INC | 3.34 Million USD | 61.508% |
ProPhase Labs, Inc. | 3.84 Million USD | 66.496% |
Phibro Animal Health Corporation | 265.91 Million USD | 99.516% |
Procaps Group S.A. | 96.83 Million USD | 98.671% |
Alvotech | 74.43 Million USD | 98.271% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.963% |
Rockwell Medical, Inc. | 5.87 Million USD | 78.08% |
Aytu BioPharma, Inc. | 12.63 Million USD | 89.813% |
SIGA Technologies, Inc. | 64.21 Million USD | 97.996% |
Tilray Brands, Inc. | 252.08 Million USD | 99.49% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 96.781% |
Shineco, Inc. | 1.58 Million USD | 18.988% |
PetIQ, Inc. | 159.3 Million USD | 99.192% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 942.329% |
Incannex Healthcare Limited | -10.01 Million USD | 112.85% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 96.64% |
Alimera Sciences, Inc. | 1.87 Million USD | 31.512% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 96.585% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | 20.088% |
Clever Leaves Holdings Inc. | 4.48 Million USD | 71.294% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -405.95% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 87.602% |
Hempacco Co., Inc. | 2.54 Million USD | 49.387% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 98.271% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 97.307% |
Lantheus Holdings, Inc. | 64.02 Million USD | 97.99% |
Currenc Group, Inc. | 732.91 Thousand USD | -75.587% |
Kamada Ltd. | 87.74 Million USD | 98.533% |
Indivior PLC | 141.79 Million USD | 99.092% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -167.079% |
Flora Growth Corp. | 8.5 Million USD | 84.874% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -405.95% |
Evolus, Inc. | 10.99 Million USD | 88.299% |
HUTCHMED (China) Limited | 50.25 Million USD | 97.439% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 98.784% |